Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07462182 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 10, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The local literature lacks comprehensive information regarding the actual incidence of intrauterine growth restriction (IUGR) and oligohydramnios and currently available therapeutic options. Therefore, the current study was planned with the objective to evaluate the impact of enoxaparin therapy compared with standard management on neonatal outcomes in pregnancies complicated by intrauterine growth restriction (IUGR) with oligohydramnios.
Trial Details
NCT Number NCT07462182
Lead Sponsor Muhammad Aamir Latif
Conditions
(from sponsor)		 Intrauterine Growth Restriction
Related terms Fetal Growth Retardation
Enrollment 108 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov